| Trial ID: | L1653 |
| Source ID: | NCT01151592
|
| Associated Drug: |
Iron Sucrose
|
| Title: |
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
|
| Acronym: |
ASSURED
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Iron Deficiency Anemia
|
| Interventions: |
DRUG: Iron Sucrose
|
| Outcome Measures: |
Primary: Incidence and severity of adverse events, overall and related from Day of first iron sucrose administration through the end of the study., Day 0 through 30 days after the final administration of iron sucrose |
|
| Sponsor/Collaborators: |
Sponsor: American Regent, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2018-01-24
|
| Locations: |
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, 19403, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01151592
|
